Weissenbacher–Zweymüller syndrome
(Redirected from Weissenbacher-Zweymuller syndrome)
Weissenbacher–Zweymuller syndrome (WZS), also called Pierre-Robin syndrome with fetal chondrodysplasia,[1] is an autosomal recessive[2] congenital disorder, linked to mutations (955 gly -> glu) in the COL11A2 gene (located on chromosomal position 6p21.3), which codes for the α2 strand of collagen type XI.[1][2] It is a collagenopathy, types II and XI disorder.
Presentation
It causes facial abnormalities, skeletal malformation and occasionally neural tube defects; the skeletal disfigurements resolve to a degree in the course of development.
Mutations in different parts of the gene may lead to deafness or Stickler syndrome type III (eye problems: myopia, retinal detachment and skeletal abnormalities).
Infants and children: Infants that are born with Weissenbacher-Zweymüller syndrome usually have short bones in their arms and legs. [3] The thigh and upper arm bones are wider than usual resulting in a dumbbell-shape while the bones of the vertebrae may be abnormal.[4] Typical abnormal facial features can be wide-set protruding eyes (hypertelorism), a small and upturned nose with a flat bridge, small jaw (micrognathia) and a cleft palate. Some infants have high-frequency hearing loss.[5] Infants may also exhibit a psychomotor delay.[6] After the period of growth deficiency the individual makes improvements in bone growth leading to a normal physical development around age 5 or 6.[7]
Adults: Many with Weissenbacher-Zweymüller syndrome have a catch-up growth phase causing the adults to not be unusually short. Many adults still will have hearing loss and typical abnormal facial features of Weissenbacher-Zweymüller syndrome. [8]
Causes
Dominant genetic disorders can be caused by just a single copy of an abnormal gene. This abnormal gene can be the result of being inherited from either parent or be a new mutation.[9] Most cases are caused by a de novo (new) mutation in the gene that occurs during the formation of the egg or sperm. These cases occur when there is no history of the disorder in the family. The COL11A2 gene is responsible for providing instructions on making one component of the type XI collagen. [10] Type XI collagen is a complex molecule that helps give structure and strength to the connective tissues.[11] Collagen is found in bone. It is also found in cartilage that makes up most of the skeleton during early development. The mutation of COL11A2 in Weissenbacher-Zweymüller syndrome disrupts the assembly of the type XI collagen molecules.[12] The malfunctioning collagen weakens the connective tissue causing impaired bone development. [13] COL11A2 is also associated with autosomal dominant non-syndromic hearing loss (ADNSHL).[14] All mutations of COL11A2 in ADNSHL are missense mutations.[15]
Diagnosis
Weissenbacher-Zweymüller syndrome is diagnosed upon a thorough clinical evaluation, detailed patient history, identification of characteristic symptom and a variety of specialized tests which includes x-rays. [16]
Treatment
There is no cure as of now. Treatment is directed towards the specific symptoms that are present in each individual. [17] Individuals with hearing loss are able to get treated with hearing aids.
Epidemiology
Weissenbacher-Zweymüller syndrome affects males and females in the same numbers. About 30 cases have been reported in medical literature. [18]This disorder can be underdiagnosed causing no true frequency in the population.[19] Only 30 cases have been reported in medical literature. [20]
Eponym
It was first characterized in 1964 by G. Weissenbacher and Ernst Zweymüller.[21][22]
References
- ↑ 1.0 1.1 Online Mendelian Inheritance in Man (OMIM) 120290
- ↑ 2.0 2.1 , Heterozygous glycine substitution in the COL11A2 gene in the original patient with the Weissenbacher-Zweymüller syndrome demonstrates its identity with heterozygous OSMED (nonocular Stickler syndrome), Am. J. Med. Genet., 1998, Vol. 80(Issue: 2), pp. 115–20, DOI: <115::AID-AJMG5>3.0.CO;2-O 10.1002/(SICI)1096-8628(19981102)80:2<115::AID-AJMG5>3.0.CO;2-O, PMID: 9805126,
- ↑ Genetics Home Reference. (2016). Retrieved from U.S. National Library of Medicine : https://ghr.nlm.nih.gov/condition/weissenbacher-zweymuller-syndrome
- ↑ Genetics Home Reference. (2016). Retrieved from U.S. National Library of Medicine : https://ghr.nlm.nih.gov/condition/weissenbacher-zweymuller-syndrome
- ↑ Genetics Home Reference. (2016). Retrieved from U.S. National Library of Medicine : https://ghr.nlm.nih.gov/condition/weissenbacher-zweymuller-syndrome
- ↑ OSMED, Heterozygous. (2006). Retrieved from National Organization for Rare Disorders: http://rarediseases.org/rare-diseases/osmed-heterozygous
- ↑ OSMED, Heterozygous. (2006). Retrieved from National Organization for Rare Disorders: http://rarediseases.org/rare-diseases/osmed-heterozygous
- ↑ Genetics Home Reference. (2016). Retrieved from U.S. National Library of Medicine : https://ghr.nlm.nih.gov/condition/weissenbacher-zweymuller-syndrome
- ↑ OSMED, Heterozygous. (2006). Retrieved from National Organization for Rare Disorders: http://rarediseases.org/rare-diseases/osmed-heterozygous
- ↑ Genetics Home Reference. (2016). Retrieved from U.S. National Library of Medicine : https://ghr.nlm.nih.gov/condition/weissenbacher-zweymuller-syndrome
- ↑ Genetics Home Reference. (2016). Retrieved from U.S. National Library of Medicine : https://ghr.nlm.nih.gov/condition/weissenbacher-zweymuller-syndrome
- ↑ Genetics Home Reference. (2016). Retrieved from U.S. National Library of Medicine : https://ghr.nlm.nih.gov/condition/weissenbacher-zweymuller-syndrome
- ↑ Genetics Home Reference. (2016). Retrieved from U.S. National Library of Medicine : https://ghr.nlm.nih.gov/condition/weissenbacher-zweymuller-syndrome
- ↑ Kim, S., Park, H., Sagong, B. et al. Genes Genom (2016). doi:10.1007/s13258-016-0440-4
- ↑ Kim, S., Park, H., Sagong, B. et al. Genes Genom (2016). doi:10.1007/s13258-016-0440-4
- ↑ OSMED, Heterozygous. (2006). Retrieved from National Organization for Rare Disorders: http://rarediseases.org/rare-diseases/osmed-heterozygous
- ↑ OSMED, Heterozygous. (2006). Retrieved from National Organization for Rare Disorders: http://rarediseases.org/rare-diseases/osmed-heterozygous
- ↑ OSMED, Heterozygous. (2006). Retrieved from National Organization for Rare Disorders: http://rarediseases.org/rare-diseases/osmed-heterozygous
- ↑ OSMED, Heterozygous. (2006). Retrieved from National Organization for Rare Disorders: http://rarediseases.org/rare-diseases/osmed-heterozygous
- ↑ OSMED, Heterozygous. (2006). Retrieved from National Organization for Rare Disorders: http://rarediseases.org/rare-diseases/osmed-heterozygous
- ↑ synd/1776 at Who Named It?
- ↑ , [Gleichzeitiges Vorkommen eines Syndroms von Pierre Robin und einer fetalen Chondrodysplasie.], Monatsschrift für Kinderheilkunde, 1964, Vol. 112, pp. 315–7, PMID: 14234962,
External links
- Pierre Robin syndrome with fetal chondrodysplasia; Weissenbacher-Zweymüller syndrome at NIH's Office of Rare Diseases
Diseases of collagen, laminin and other scleroproteins | ||||||
---|---|---|---|---|---|---|
see also fibrous proteins
|
This article is a stub. You can help WikiMD by registering to expand it. |
Weissenbacher–Zweymüller syndrome
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD